alanylglutamine has been researched along with Clostridioides difficile Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archbald-Pannone, L; Bansal, EN; Behm, BW; Costa, DVDS; Shin, JH; Swann, JR; Targonski, PV; Wang, XQ; Warren, CA; Wu, M | 1 |
| Braga Neto, MB; Costa, LB; Guerrant, RL; Kolling, GL; Li, Y; Lima, AA; Oliveira, RA; Rodrigues, RS; Warren, CA; Zaja-Milatovic, S | 1 |
1 trial(s) available for alanylglutamine and Clostridioides difficile Infection
| Article | Year |
|---|---|
Alanyl-glutamine supplementation for
Topics: Adolescent; Adult; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Dietary Supplements; Double-Blind Method; Humans; Inflammation; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Treatment Outcome | 2023 |
1 other study(ies) available for alanylglutamine and Clostridioides difficile Infection
| Article | Year |
|---|---|
Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.
Topics: Animals; Apoptosis; Bacterial Proteins; Bacterial Toxins; Cell Line; Cell Proliferation; Clostridioides difficile; Clostridium Infections; Dipeptides; Disease Models, Animal; Enterocytes; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Necrosis; Rats; Vancomycin | 2013 |